Amyloid Solution Inc.
PrivateLast Round
Series C
May 18, 2022
Est. Valuation
$193.7M
Total Funding Raised
$66.6M
Company Overview
Amyloid Solution Inc. is a biotechnology company that develops therapeutic drugs for the treatment of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amyloid Solution Inc. Comparables
Compare Amyloid Solution Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AriBio | 88% | |
| Adel, Inc. | 81% | |
| Alzheon | 79% |
Amyloid Solution Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 18, 2022 | ||||
| Series B Extension | Jun 20, 2020 | ||||
| Series B | Apr 10, 2020 | ||||
| Series A | Mar 26, 2019 | ||||
| Accelerator | Dec 1, 2017 |
Amyloid Solution Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Investment | Series B Extension |
| POSCO Capital | Series B Extension, Series C |
| KCLAVIS Investment | Series B |
| Starset Investment | Series A |
| TS Investment | Series A, Series B, Series C |
| Innopolis Partners | Series A |
| Wonik Investment Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2025
Presented lead programs at the Alzheimer's Association International Conference 2025.
- May 18, 2022
$35.5M round with participation from POSCO Capital.
Recent news
Latest coverage and updates
- is_developingJul 2, 2026
Amyloid Solution Inc. is developing innovative treatments for Alzheimer's disease on Jul 2nd '26.
Amyloid Solution Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amyloid Solution Inc.'s valuation, stock price, and market status.
Is Amyloid Solution Inc. a public or private company?
Amyloid Solution Inc. is a private company.
What is the current stock price of Amyloid Solution Inc.?
Amyloid Solution Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Amyloid Solution Inc. worth (valuation)?
Amyloid Solution Inc.'s valuation is estimated at $185.3M based on funding round data.
Can I buy Amyloid Solution Inc. stock?
Amyloid Solution Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amyloid Solution Inc.'s last funding round?
Amyloid Solution Inc.'s most recent funding round was Series C on May 3, 2022.
Who are the main investors in Amyloid Solution Inc.?
Key investors in Amyloid Solution Inc. include KB Investment, POSCO Capital, Starset Investment, TS Investment, Innopolis Partners.
Will Amyloid Solution Inc. IPO soon?
No public IPO plans have been announced for Amyloid Solution Inc..
How can I track Amyloid Solution Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amyloid Solution Inc.'s secondary market activity and sign up for updates.